3Cheng CY, Chen GH, Chang CS, et al. Sclerotherapy on liver cirrhosis with esophageal variceal bleeding, eight years of experi ence. Zhonghua Yi Xue ZaZhi (Taipei), 1994, 54:321-328. 被引量：1
4Hashizume M, Kitano S, Koyanagi N, et al. Endoscopic injection sclerotherapy for 1 000 patients with esophageal varices: a nine year prospective study. Hepatology, 1992, 15;69-75. 被引量：1
5Tomikawa M, Hashizume M, Okita K, et al. Endoscopic injection sclerotherapy in the management of 2105 patients with esophageal varices. Surgery, 2002. 1:31 (1 Suppl) : S171-S175. 被引量：1
6Cheng L, Wang Z, Li C, et al. Experience in sclerotherapy for esophagogastric variceal bleeding. Chin Med J (Engl), 2002, 115:919-922. 被引量：1
7Lo GH. Lai KH, Cheng JS. el al. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. Hepatology, 2000, 32:461-465. 被引量：1
8Akahoshi T, Hashizume M, Shimabukuro R, et al. Long-term results of endoscopic Histoacryl injection sclerotherapy for gastric variceal bleeding:a 10 year experience. Surgery, 2002, 131 (1 Suppl):S176-S181. 被引量：1
9Reyes Dorantes AA. Endoscopic management of variceal bleed ing. Rev Gastroenterol Mex, 2005, 70:50-55. 被引量：1
10Zaman A. Current Management of esophageal varices. Curr Treat Options Gastroenterol, 2003. 6:499-507. 被引量：1
